469-05-010 ISMRM Abstract

Multicolor 19F MRI using Spectral Hadamard-Encoding

Primary: Contrast Mechanisms - Non-Proton

Secondary: Preclinical Animal & in vitro MR - Biomarkers

469-05-010 · Non-Proton MRI: Methods and Applications · Tuesday, 12 May, 4:00 PM–4:55 PM · Digital Posters Row J

Keywords: Inflammation 19F MRI Fluorine-19

Accepted

Kian Tadjalli Mehr ¹, Felix Spreter¹, Simon Reiss¹, Johannes Fischer¹, Ali C Özen¹, Natalie Hoppe², Gunjan Arya², Alexander Maier², Michael Bock¹

¹Division of Medical Physics, Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

²Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Presenting Author: Kian Tadjalli Mehr

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Jacoby C, Temme S, Mayenfels F, et al. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half-lives and sensitivity. NMR Biomed. 2014;27(3):261-271. doi:10.1002/nbm.3059 [doi]

2. Senders ML, Meerwaldt AE, van Leent MMT, et al. Probing myeloid cell dynamics in ischemic heart disease by nanotracer hot spot imaging. Nat Nanotechnol. 2020;15(5):398-405. doi:10.1038/s41565-020-0642-4 [doi]

3. Ahrens ET, Helfer BM, O’Hanlon CF, Schirda C. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magnetic Resonance in Medicine. 2014;72(6):1696-1701. doi:10.1002/mrm.25454 [doi]

4. Srinivas M, Heerschap A, Ahrens ET, Figdor CG, de Vries IJM. 19F MRI for quantitative in vivo cell tracking. Trends Biotechnol. 2010;28(7):363-370. doi:10.1016/j.tibtech.2010.04.002 [doi]

5. Chapelin F, Capitini CM, Ahrens ET. Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer. J Immunother Cancer. 2018;6:105. doi:10.1186/s40425-018-0416-9 [doi]

6. Schoormans J, Calcagno C, Daal MRR, et al. An iterative sparse deconvolution method for simultaneous multicolor 19 F-MRI of multiple contrast agents. Magn Reson Med. 2020;83(1):228-239. doi:10.1002/mrm.27926 [doi]

7. Chen J, Ahrens ET, Pal P. Physics-Driven Learned Deconvolution of Multi-Spectral Cellular MRI with Radial Sampling. In: 2023 57th Asilomar Conference on Signals, Systems, and Computers. ; 2023:1453-1457. doi:10.1109/IEEECONF59524.2023.10476927 [doi]

8. Flögel U, Temme S, Jacoby C, et al. Multi-targeted 1H/19F MRI unmasks specific danger patterns for emerging cardiovascular disorders. Nat Commun. 2021;12(1):5847. doi:10.1038/s41467-021-26146-6 [doi]

9. Akazawa K, Sugihara F, Nakamura T, et al. Perfluorocarbon-Based 19F MRI Nanoprobes for In Vivo Multicolor Imaging. Angewandte Chemie International Edition. 2018;57(51):16742-16747. doi:10.1002/anie.201810363 [doi]

10. Tadjalli Mehr K, Fischer J, Spreter F, et al. Radial Hadamard-encoded 19F-MRI. Magn Reson Mater Phy. May 2025. doi:10.1007/s10334-025-01254-2 [doi]

11. Darçot E, Colotti R, Brennan D, Deuchar GA, Santosh C, van Heeswijk RB. A characterization of ABL-101 as a potential tracer for clinical fluorine-19 MRI. NMR Biomed. 2020;33(1):e4212. doi:10.1002/nbm.4212 [doi]

12. Özen AC, Spreter F, Schimpf W, et al. Scalable and modular 8-channel transmit and 8-channel flexible receive coil array for 19 F MRI of large animals. Magn Reson Med. 2023;89(3):1237-1250. doi:10.1002/mrm.29490 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/469-05-010